Homocysteine level and metabolism in ischemic stroke in the population of Northern Poland

Clinical Biochemistry

Volumn 42, Issue 6, 2009, Pages 442-447

  Sawuła, Wojciech ^a   Banecka Majkutewicz, Zyta ^b   Kadziński, Leszek ^a   Jakóbkiewicz Banecka, Joanna ^a   Wegrzyn, Grzegorz ^a   Nyka, Walenty ^b   Banecki, Bogdan ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

Homocysteine; PLP; Polymorphisms; Risk factors; Stroke

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYSTATHIONINE BETA SYNTHASE; HOMOCYSTEINE; PYRIDOXINE;

ARTICLE; BRAIN; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME METABOLISM; HEREDITY; HUMAN; HYPERHOMOCYSTEINEMIA; MAJOR CLINICAL STUDY; POLAND; POPULATION; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; VITAMIN BLOOD LEVEL;

5,10-METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BRAIN INFARCTION; CYSTATHIONINE BETA-SYNTHASE; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; POLAND; POLYMORPHISM, GENETIC; PYRIDOXAL PHOSPHATE; RETROSPECTIVE STUDIES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; VITAMIN B 6;

EID: 61849137780     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2008.12.019     Document Type: Article

References (29)

1. Prasad K. Homocysteine, a risk factor for cardiovascular disease. Int. J. Angiol. 8 (1999) 76-86
2. Refsum H., Ueland P.M., Nygård O., et al. Homocysteine and cardiovascular disease. Annu. Rev. Med. 49 (1998) 31-62
3. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288 16 (2002) 2015-2022
4. Veerkamp M.J., de Graaf J., den Heijer M., et al. Plasma homocysteine in subjects with familial combined hyperlipidemia. Atherosclerosis 66 (2003) 111-117
5. Alfthan G., Pekkamen J., and Janhiainen M. Relation of serum homocysteine and lipoprotein (a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 106 (1994) 9-19
6. Knekt P., Reunanen A., Alfthan G., et al. Hyperhomocysteinemia: a risk factor or a consequence of coronary heart disease?. Arch. Intern. Med. 61 (2001) 1589-1594
7. Toohey J.I. Mercaptopropionaldehyde from homocysteine: implications for Alzheimer's disease. J. Alzheimer's Dis. 12 3 (2007) 241-243
8. Jakubowski H. Metabolism of homocysteine thiolactone in human cell cultures: possible mechanism for pathological consequences of elevated homocysteine levels. J. Biol. Chem. 272 (1997) 1935-1942
9. Finkelstein J.D., and Martin J.J. Homocysteine. Int. J. Biochem. Cell Biol. 32 (2000) 385-389
10. 6 in lowering fasting plasma homocysteine concentrations in patients with coronary artery disease. Eur. J. Clin. Nutr. 58 3 (2004) 481-487
11. Ebbing M., Bleie Ø., Ueland P.M., et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. JAMA 300 7 (2008) 795-804
12. Pitsavos C., Panagiotakos D.B., Chrysohoou C., et al. Epidemiology of cardiovascular risk factors in Greece; aims, design and baseline characteristics of the ATTICA Study. BMC Public Health 3 32 (2003) 1-9
13. Weisberg I., Tran P., Christensen B., et al. A second genetic polymorphism in methylenetetrahydrofolate reductase (MTHFR) associated with decreased enzyme activity. Mol. Genet. Metab. 64 (1998) 169-172
14. Jakóbkiewicz-Banceka J., Kloska A., Stepnowska M., et al. A bacterial model for studying effects of human mutations in vivo: Escherichia coli strains mimicking a common polymorphism in the human MTHFR gene. Mutat. Res. 578 1-2 (2005) 175-186
15. Selhub J., Jacques P.F., Wilson P.W.F., et al. Vitamin status and intake as primary determinants of homocysteinemia in the elderly. JAMA 270 (1993) 2693-2698
16. Smulders Y.M., Raki M., Slaats E.H., et al. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria and cardiovascular disease. Diabetes Care 23 (2000) 1816-1822
17. Wollesen F., Brattström L., Refsum H., et al. Plasma total homocysteine and cysteine in relation to glomerular filtration rate in diabetes mellitus. Kidney Int. 55 (1999) 1028-1035
18. Sawuła W., Banecka-Majkutewicz Z., Kadziński L., et al. Improved HPLC method for total plasma homocysteine detection and quantification. Acta Biochim. Pol. 55 (2008) 119-125
19. Deitrick C.L., Katholi R.E., Huddleston D.J., et al. Clinical adaptation of a high-performance liquid chromatographic method for the assay of pyridoxal 5′-phosphate in human plasma. J. Chromatogr., B 751 (2001) 383-387
20. Hackam D.G., and Anand S.S. Emerging risk factors for atherosclerotic vascular disease. J. Am. Med. Assoc. 290 (2003) 932-940
21. Bostom A.G., Silberhatz H., Rosenberg I.H., et al. Non-fasting plasma total homocysteine levels and all-cause and cardiovascular disease mortality in elderly Framingham men and women. Arch. Intern. Med. 159 (1999) 1077-1080
22. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. BMJ 325 (2002) 1202-1206
23. Linnebank M., Moskau S., Farmand S., et al. Homocysteine and carotid intima-media thickness in a German population: lack of clinical relevance. Stroke 37 (2006) 2840-2842
24. Ranjith N., Pegoraro R.J., and Rom L. Risk factors and methylenetetrahydrofolate reductase gene polymorphism in a young South African Indian-based population with acute myocardial infarction. Cardiovasc. J. South. Afr. 14 (2003) 27-132
25. Kumar J., Das S.K., Sharma P., et al. Homocysteine levels are associated with MTHFR A1298C polymorphism in Indian population. J. Hum. Genet. 50 (2005) 655-663
26. Inbal A., Freimark D., Modan B., et al. Synergistic effects of prothrombotic polymorphisms and atherogenic factors on the risk of myocardial infarction in young males. Blood 93 (1999) 2186-2190
27. Amouzou E.K., Chabi N.W., Adjalla C.E., et al. High prevalence of hyperhomocysteinemia related to folate deficiency and the 677c->T mutation of the gene encoding methylenetetrahydrofolate reductase in coastal West Africa. Am. J. Clin. Nutr. 79 (2004) 619-624
28. Mager A., Koren-Morag N., Shohat M., et al. Family history, plasma homocysteine and age at onset of symptoms of myocardial ischemia in patients with different methylenetetrahydrofolate reductase genotypes. Am. J. Cardiol. 95 (2005) 1420-1424
29. Agnati L.F., Genedani S., Rasio G., et al. Studies on homocysteine plasma levels in Alzheimer's patients. Relevance for neurodegeneration. J. Neural Transm. 112 (2005) 163-169